Unpad Researchers Revealed Lack of China’s Covid-19 Sinovac Vaccines

BANDUNG, KOMPAS.com – The head of the clinical trials research team for the Covid-19 vaccine phase 3 at the Padjajaran University School of Medicine, Professor Kusnandi Rusmil, revealed the lack of the Covid-19 vaccine from Sinovac, China.

“The lack of vaccines (originating from China) is not so immunogenic, so you have to inject it more than once,” said Kusnandi at the Anniversary of the University of Padjadjaran (Unpad) that took place virtually on Friday (9/11 / 2020).

However, according to Kusnadi, it is safer than other vaccines that have been tested in other countries.

Also read: Erick Thohir Call 2 Covid-19 vaccine injection schemes in the community

Kusnandi explained that various types of vaccines are being developed in the world, either with live or dead viruses.

For live viruses, the vaccine usually consists of two live viruses, which are then injected into people.

However, it turned out that something did not match, so he stopped.

Then the vaccine for the virus that died first, as is now being clinically tested in Indonesia.

Also Read: Research Shows Indonesian Vaccine Confidence Level Decreases

However, the drawback is that the vaccine is not very immunogenic, so it must be injected more than once.

This is why in phase three vaccine clinical trials, each volunteer receives two injections.

Kusnandi revealed that so far there is no cure for the corona virus.

The countries of the world compete to make vaccines.

Indonesia itself is working with China to develop this vaccine.

Also read: Volunteers injected with the Chinese-made Covid-19 vaccine